摘要
多发性硬化 (MS)的发病机制尚未完全明确 ,目前认为 MS是 CD4 +Th1细胞介导的自身免疫性疾病。本文综述在 MS中细胞因子、基因。
出处
《中国神经免疫学和神经病学杂志》
CAS
2001年第3期157-161,共5页
Chinese Journal of Neuroimmunology and Neurology
基金
上海市科学技术发展基金资助项目 (黏附分子及转录因子在 MS及 EAE发病机制中的研究 )
参考文献21
-
1[1]Zang YC, Halder JB, Samanta AK, et al. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta[J]. J Neuroimmunol, 2001,112(1-2):174-180.
-
2[2]Lopez E, Racadot E, Bataillard M,et al. Interferon gamma, IL2, IL4, IL10 and TNFalpha secretions in multiple sclerosis patients treated with an anti-CD4 monoclonal antibody[J]. Autoimmunity, 1999,29(2):87-92.
-
3[3]Coles AJ, Wing MG, Molyneux P, et al. Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis[J]. Ann Neurol, 1999,46(3):296-304.
-
4[4]Jonathan L Carter, Scottsdale AZ, Mark Agius, et al. A placebo-controlled phamacodynamic pharmacokintic tolerability and safety study of three doses of intravenous natilizumab in multiple sclerosis[J]. Neurology, 2000,(supple 3):A259.
-
5[5]Kanwar JR, Harrison JE, Wang D,et al. Beta7 integrins contribute to demyelinating disease of the central nervous system[J]. J Neuroimmunol, 2000,103(2):146-152.
-
6[6]Rottman JB, Slavin AJ, Silva R, et al. Leukocyterecruitment during onset of experimental allergicencephalomyelitis is CCR1 dependent[J]. Eur J Immunol, 2000,30(8):2372-2377.
-
7[7]Kieseier BC, Seifert T, Giovannoni G, et al. Matrix metalloproteinases in inflammatory demyelination: targets for treatment[J]. Neurology, 1999,53(1):20-25.
-
8[8]Ge Y, Grossman RI, Udupa JK, et al. Glatiramer acetate (copaxone) treatment in relapsing-remitting MS: quantitative MR assessment[J]. Neurology, 2000,54(4):813-817.
-
9[9]Ge Y, Grossman RI, Udupa JK, et al. Glatiramer acetate (Copaxone) treatment in relapsing-remitting MS: quantitative MR assessment[J]. Neurology,2000,54(4):813-817.
-
10[10]Zang YC, Hong J, Rivera VM, et al. Preferential recognition of TCR hypervariable regions by human anti-idiotypic T cells induced by T cell vaccination[J]. J Immunol, 2000,164(8):4011-4017.
同被引文献56
-
1黄德晖,吴卫平,蒲传强,朱克.多发性硬化226例临床分析[J].中国神经免疫学和神经病学杂志,2003,10(3):152-155. 被引量：58
-
2孙成文,曾庆华,孙晓霞,安刚,战术,钟国赣,卫永弟,安占元.黄芪皂甙对小鼠T淋巴细胞钙依赖性钾通道的影响[J].白求恩医科大学学报,1996,22(2):125-126. 被引量：19
-
3张为,曾丽.多发性硬化治疗进展[J].医学综述,2006,12(8):478-480. 被引量：1
-
4赵葆洵 刘秀琴 等.我国多发性硬化的临床特点－－附70例临床分析[J].中华神经精神科杂志,1979,12:169-169.
-
5Zivadinov R,Rudick RA,DeMasi R,et al.Effects of Ⅳ methylperdniolone on brain atrophy in relapsing-remitting MS[J].Neurology,2001,57(7):1239-1247.
-
6Tullman MJ,Lublin FD,Miller AE.Immunotherapy of multiplesclerosis current practice and future directions[J].J Rehabil Res Dev,2002,39(2):273-285.
-
7Kieseier BC,Hartung HP.Current disease modifying therapies in multiple sclerosis[J].2003 Semin Neurol,2003,23:133-146.
-
8Secondary Progressive Efficacy Clinical Trial of Recombinant Interferon-beta-la in MS(SPECTRIMS)Study Group.Randomized controlled trial of interferon-beta-la in secondary progressive MS clinical results[J],Neurology,2001,56(11):1496-1504.
-
9Coles AJ.Neutralising antibodies to the beta interferons[J].J Neurol Neurosurg Psychiatry,2002,73(2):110-111.
-
10Coyle P.Results of comparative efficacy trial using two formulations of interferon beta-la in RRMS[J].J Rehabil Res Dev,2002,39(2):211-224.
引证文献7
-
1陈琳,黄红云,王锐,修波,王洪美.嗅鞘细胞移植治疗多发性硬化的初步分析附1例报告[J].海军总医院学报,2003,16(4):240-242. 被引量：2
-
2李爱云,闫荔,王塑华.多发性硬化的临床观察[J].山西医药杂志,2005,34(1):17-18.
-
3毕峰,杨明妍,刘刚.多发性硬化34例临床分析[J].当代医学,2009,15(30):66-67. 被引量：5
-
4单敏,杨明妍,冯文勇.多发性硬化的药物治疗进展[J].当代医学,2010,16(36):15-16. 被引量：3
-
5任晓威,薛晓文.治疗多发性硬化症的选择性鞘胺醇-1-磷酸受体1激动剂的临床研究进展[J].临床合理用药杂志,2014,7(17):170-172. 被引量：1
-
6范柳芳,林艾羽,黄楦槟,童铷烯,黄友贞,陈金雄.改良平复汤对多发性硬化患者T淋巴细胞亚群的影响[J].光明中医,2019,34(2):228-229. 被引量：1
-
7楚兰,马莉,杨洁,李红.火把花根片对多发性硬化患者外周血T淋巴细胞亚群的影响[J].中风与神经疾病杂志,2003,20(2):178-179. 被引量：4
二级引证文献15
-
1郝勇,刘海沛,王舒.中西医治疗多发性硬化的研究进展[J].天津中医学院学报,2004,23(4):219-220.
-
2韩玉,万屏.昆明山海棠药理作用研究进展[J].国外医学（中医中药分册）,2005,27(5):272-275. 被引量：25
-
3樊永平.中医药治疗多发性硬化的疗效与可能机理[J].继续医学教育,2006,20(6):53-56. 被引量：3
-
4石厚银,黄家骏,扶世杰.嗅鞘细胞移植治疗脊髓损伤的进展[J].泸州医学院学报,2008,31(3):346-348.
-
5沈鸿婷,汤湘江,杜宝新.多发性硬化20例临床分析[J].医药论坛杂志,2010,31(15):37-39.
-
6单敏,杨明妍,冯文勇.多发性硬化的药物治疗进展[J].当代医学,2010,16(36):15-16. 被引量：3
-
7宋俐.多发性硬化58例诊治分析[J].中国误诊学杂志,2011,11(6):1438-1438. 被引量：1
-
8李静,李婧,刘茵,韦淑萍.心理护理干预对多发性硬化患者治疗效果的影响[J].武警后勤学院学报（医学版）,2012,21(8):625-627. 被引量：3
-
9王向东,万丽萍,刘曾旭.嗅鞘细胞移植治疗脊髓损伤:问题与瞻望[J].中国组织工程研究,2012,16(40):7553-7557.
-
10曾荣,王燕,胡华,寇志刚.周德生教授辨治多发性硬化的学术见解及临床经验[J].世界中医药,2014,9(1):61-63. 被引量：6
